A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy

Completed · Phase 4 · Has a placebo group

Conditions studied: Hypertension

In brief

This study will evaluate the long-term efficacy of nebivolol monotherapy in patients with stage 1 or stage 2 hypertension after the withdrawal of active medication.

Key facts

Study ID

NCT00785512

Run by

Forest Laboratories

People needed

207

Starts

2008-11-01

Last updated by the study team

2010-09-15

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• male and female outpatients 18 to 79 years of age
• Females must be post-menopausal, or not pregnant and using an approved contraceptive regimen
• meet criteria for stage I or II hypertension
• currently not treated, or being treated with no more than two anti-hypertensive medications

You may not qualify if…

• type 1 or type 2 diabetes
• secondary hypertension
• evidence of other concurrent disease or conditions that might interfere with the conduct of the study
• treatment with any investigational study drug within 30 days of Screening (Visit 1)
• have a history of hypersensitivity to nebivolol or other β-blockers

Where it is running

• Forest Investigative Site — Chandler, Arizona, United States
• Forest Investigative Site — Phoenix, Arizona, United States
• Forest Investigative Site — Los Angeles, California, United States
• Forest Investigative Site — Bradenton, Florida, United States
• Forest Investigative Site — Brooksville, Florida, United States
• Forest Investigative Site — DeLand, Florida, United States
• Forest Investigative Site — Hollywood, Florida, United States
• Forest Investigative Site — Miami, Florida, United States
• Forest Investigative Site — Miami, Florida, United States
• Forest Investigative Site — Miami, Florida, United States
• Forest Investigative Site — Pembroke Pines, Florida, United States
• Forest Investigative Site — St. Petersburg, Florida, United States
• Forest Investigative Site — Auburn, Maine, United States
• Forest Investigative Site — Cary, North Carolina, United States
• Forest Investigative Site — Hickory, North Carolina, United States
• Forest Investigative Site — Salisbury, North Carolina, United States
• Forest Investigative Site — Wilmington, North Carolina, United States
• Forest Investigative Site — Winston-Salem, North Carolina, United States
• Forest Investigative Site — Cincinnati, Ohio, United States
• Forest Investigative Site — Marion, Ohio, United States
• Forest Investigative Site — Lancaster, Pennsylvania, United States
• Forest Investigative Site — Mt. Pleasant, South Carolina, United States
• Forest Investigative Site — Simpsonville, South Carolina, United States
• Forest Investigative Site — New Tazewell, Tennessee, United States
• Forest Investigative Site — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.